3.1 Bronchodilators
| NICE CG101 | Chronic obstructive pulmonary disease: Management of chronic obstructive pulmonary disease in adults in primary and secondary care | Jun 10 |
| 2011 SIGN Guidelines | Management of Asthma | |
| Refer to latest BTS | www.brit-thoracic.org.uk | |
| & SIGN guidelines | www.sign.ac.uk for asthma |
Spacer devices may be useful for patients with poor inhalation technique, children, and for those prone to oral candidiasis with inhaled steroids. They should be prescribed for patients receiving high dose steroids (>800mcg/day of beclomethasone or budesonide)
3.1.1 Adrenoceptor agonists
Short-Acting Beta2 Agonists
| 1st |  |
SALBUTAMOL CFC-free MDI/ Easi Breathe/ Accuhaler/ Nebules/ Injection |
| 1st | |
TERBUTALINE Turbohaler/ Nebules |
3.1.1.1 Selective beta2 agonists
Long-Acting Beta2 Agonists (LABA)
|
FORMOTEROL MDI | |
|
SALMETEROL MDI/ Accuhaler (For existing patients) | |
|
ONBREZ BREEZHALER |
3.1.2 Antimuscarinic Bronchodilators
| 1st | |
GLYCOPYRRONIUM (Seebri Breezhaler) | |
| 1st | |
IPRATROPIUM MDI/ Nebules | |
| 1st | |
TIOTROPIUM | |
|
INCRUSE ELLIPTA | ||
|
DUAKLIR GENUAIR | ||
|
ACLIDINIUM BROMIDE (Yellow) (Eklira Genuair) |
3.1.3 Theophylline
| 1st | |
AMINOPHYLLINE | |
| 1st | |
THEOPHYLLINE Tablet/ MR Tablet/ Liquid (Nuelin/ Slo-Phyllin) | |
| Other brands of theophylline and aminophylline are available for existing patients. | |||
|
CAFFEINE CITRATE Liquid/ Injection (Neonatal unit only) | ||
3.1.4 Compound bronchodilator preparations
| |
ANORO ELLIPTA | ||
|
ULTIBRO BREEZHALER |
Related pages
3.2 Corticosteroids3.3 Cromoglicate and related therapy and leukotrine receptor antagonists, and phosphodiesterase typre-4 inhibitors3.4 Antihistamines,hyposensitisation, and allergic emergencies3.5 Respiratory stimulants and pulmonary surfactants3.6 Oxygen3.7 Mucolytics3.9 Cough Preparations3.10 Systemic nasal decongestants3.11 Antifibrotics
